Cargando…

From Forensics to Clinical Research: Expanding the Variant Calling Pipeline for the Precision ID mtDNA Whole Genome Panel

Despite a multitude of methods for the sample preparation, sequencing, and data analysis of mitochondrial DNA (mtDNA), the demand for innovation remains, particularly in comparison with nuclear DNA (nDNA) research. The Applied Biosystems™ Precision ID mtDNA Whole Genome Panel (Thermo Fisher Scientif...

Descripción completa

Detalles Bibliográficos
Autores principales: Cortes-Figueiredo, Filipe, Carvalho, Filipa S., Fonseca, Ana Catarina, Paul, Friedemann, Ferro, José M., Schönherr, Sebastian, Weissensteiner, Hansi, Morais, Vanessa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584537/
https://www.ncbi.nlm.nih.gov/pubmed/34769461
http://dx.doi.org/10.3390/ijms222112031
_version_ 1784597473290878976
author Cortes-Figueiredo, Filipe
Carvalho, Filipa S.
Fonseca, Ana Catarina
Paul, Friedemann
Ferro, José M.
Schönherr, Sebastian
Weissensteiner, Hansi
Morais, Vanessa A.
author_facet Cortes-Figueiredo, Filipe
Carvalho, Filipa S.
Fonseca, Ana Catarina
Paul, Friedemann
Ferro, José M.
Schönherr, Sebastian
Weissensteiner, Hansi
Morais, Vanessa A.
author_sort Cortes-Figueiredo, Filipe
collection PubMed
description Despite a multitude of methods for the sample preparation, sequencing, and data analysis of mitochondrial DNA (mtDNA), the demand for innovation remains, particularly in comparison with nuclear DNA (nDNA) research. The Applied Biosystems™ Precision ID mtDNA Whole Genome Panel (Thermo Fisher Scientific, USA) is an innovative library preparation kit suitable for degraded samples and low DNA input. However, its bioinformatic processing occurs in the enterprise Ion Torrent Suite™ Software (TSS), yielding BAM files aligned to an unorthodox version of the revised Cambridge Reference Sequence (rCRS), with a heteroplasmy threshold level of 10%. Here, we present an alternative customizable pipeline, the PrecisionCallerPipeline (PCP), for processing samples with the correct rCRS output after Ion Torrent sequencing with the Precision ID library kit. Using 18 samples (3 original samples and 15 mixtures) derived from the 1000 Genomes Project, we achieved overall improved performance metrics in comparison with the proprietary TSS, with optimal performance at a 2.5% heteroplasmy threshold. We further validated our findings with 50 samples from an ongoing independent cohort of stroke patients, with PCP finding 98.31% of TSS’s variants (TSS found 57.92% of PCP’s variants), with a significant correlation between the variant levels of variants found with both pipelines.
format Online
Article
Text
id pubmed-8584537
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85845372021-11-12 From Forensics to Clinical Research: Expanding the Variant Calling Pipeline for the Precision ID mtDNA Whole Genome Panel Cortes-Figueiredo, Filipe Carvalho, Filipa S. Fonseca, Ana Catarina Paul, Friedemann Ferro, José M. Schönherr, Sebastian Weissensteiner, Hansi Morais, Vanessa A. Int J Mol Sci Article Despite a multitude of methods for the sample preparation, sequencing, and data analysis of mitochondrial DNA (mtDNA), the demand for innovation remains, particularly in comparison with nuclear DNA (nDNA) research. The Applied Biosystems™ Precision ID mtDNA Whole Genome Panel (Thermo Fisher Scientific, USA) is an innovative library preparation kit suitable for degraded samples and low DNA input. However, its bioinformatic processing occurs in the enterprise Ion Torrent Suite™ Software (TSS), yielding BAM files aligned to an unorthodox version of the revised Cambridge Reference Sequence (rCRS), with a heteroplasmy threshold level of 10%. Here, we present an alternative customizable pipeline, the PrecisionCallerPipeline (PCP), for processing samples with the correct rCRS output after Ion Torrent sequencing with the Precision ID library kit. Using 18 samples (3 original samples and 15 mixtures) derived from the 1000 Genomes Project, we achieved overall improved performance metrics in comparison with the proprietary TSS, with optimal performance at a 2.5% heteroplasmy threshold. We further validated our findings with 50 samples from an ongoing independent cohort of stroke patients, with PCP finding 98.31% of TSS’s variants (TSS found 57.92% of PCP’s variants), with a significant correlation between the variant levels of variants found with both pipelines. MDPI 2021-11-06 /pmc/articles/PMC8584537/ /pubmed/34769461 http://dx.doi.org/10.3390/ijms222112031 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Cortes-Figueiredo, Filipe
Carvalho, Filipa S.
Fonseca, Ana Catarina
Paul, Friedemann
Ferro, José M.
Schönherr, Sebastian
Weissensteiner, Hansi
Morais, Vanessa A.
From Forensics to Clinical Research: Expanding the Variant Calling Pipeline for the Precision ID mtDNA Whole Genome Panel
title From Forensics to Clinical Research: Expanding the Variant Calling Pipeline for the Precision ID mtDNA Whole Genome Panel
title_full From Forensics to Clinical Research: Expanding the Variant Calling Pipeline for the Precision ID mtDNA Whole Genome Panel
title_fullStr From Forensics to Clinical Research: Expanding the Variant Calling Pipeline for the Precision ID mtDNA Whole Genome Panel
title_full_unstemmed From Forensics to Clinical Research: Expanding the Variant Calling Pipeline for the Precision ID mtDNA Whole Genome Panel
title_short From Forensics to Clinical Research: Expanding the Variant Calling Pipeline for the Precision ID mtDNA Whole Genome Panel
title_sort from forensics to clinical research: expanding the variant calling pipeline for the precision id mtdna whole genome panel
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584537/
https://www.ncbi.nlm.nih.gov/pubmed/34769461
http://dx.doi.org/10.3390/ijms222112031
work_keys_str_mv AT cortesfigueiredofilipe fromforensicstoclinicalresearchexpandingthevariantcallingpipelinefortheprecisionidmtdnawholegenomepanel
AT carvalhofilipas fromforensicstoclinicalresearchexpandingthevariantcallingpipelinefortheprecisionidmtdnawholegenomepanel
AT fonsecaanacatarina fromforensicstoclinicalresearchexpandingthevariantcallingpipelinefortheprecisionidmtdnawholegenomepanel
AT paulfriedemann fromforensicstoclinicalresearchexpandingthevariantcallingpipelinefortheprecisionidmtdnawholegenomepanel
AT ferrojosem fromforensicstoclinicalresearchexpandingthevariantcallingpipelinefortheprecisionidmtdnawholegenomepanel
AT schonherrsebastian fromforensicstoclinicalresearchexpandingthevariantcallingpipelinefortheprecisionidmtdnawholegenomepanel
AT weissensteinerhansi fromforensicstoclinicalresearchexpandingthevariantcallingpipelinefortheprecisionidmtdnawholegenomepanel
AT moraisvanessaa fromforensicstoclinicalresearchexpandingthevariantcallingpipelinefortheprecisionidmtdnawholegenomepanel